Glycobiology products are widely used for analysis of cell surface markers, which can act as diagnostic or therapeutic targets. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.
According to the new market research report "Glycomics / Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021", published by MarketsandMarkets™, The global glycobiology market is expected to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%.
Don't miss out on business opportunities in Glycomics / Glycobiology Market
Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525
On the basis of product, the glycobiology market is segmented into enzymes, instruments, kits, and reagents.
The enzymes segment is projected to grow at the highest CAGR during the forecast period. This growth is mainly attributed to their consumable nature and wide applications in a variety of R&D and drug discovery procedures. The enzymes segment is further divided into glycosidases, glycosyltransferases, neuraminidases, sialyltransferases, and other enzymes.
Browse in-depth TOC on " Glycomics / Glycobiology Market "
91 – Tables
32 – Figures
158 – Pages
Read more: https://www.marketsandmarkets.com/PressReleases/glycobiology.asp
Glycomics is an important tool for analyzing target drugs and developing relevant therapeutic leads, which helps in accelerating drug development. One of the most crucial bottlenecks of the drug discovery process includes the development of the right drug for the right target. More than 90% of druggable targets belong to the class of proteins. Glycomics research is associated with proteomic processes to cater to the needs of the pharmaceutical industry for the identification of new targets to gain insights into drug actions. Glycomics also aids in the investigation of defective proteins and how they may cause particular diseases, which by extension helps in developing new drugs. The use of glycomics has increased significantly as it enables biomarker analysis, carbohydrate synthesis, glycoengineering, as well as drug and vaccine discovery and development.
Glycobiology market is segmented into North America, Asia, Europe, and RoW
The Asian market is estimated to grow at the highest CAGR during the forecast period. This growth is mainly attributed to the increasing commercialization of R&D by pharmaceutical and biotechnology companies, growing demand for personalized medicine, and rising importance of companion diagnostics. Over the past few years, the overall Asian region has witnessed growth in the glycomics market as North American and European pharmaceutical drug manufacturers find it cost-effective to outsource their glycomics-based work to Asian manufacturers or set up their manufacturing facilities in Asian countries.
Request Sample Report Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525
The key players in the glycobiology market include Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).
Glycomics / Glycobiology Market Recent Development | Industry Report 2021
This report studies the global Glycomics/ Glycobiology market, analyzes and researches the Glycomics/ Glycobiology development status and forecast in United States, EU, Japan, China, India and Southeast Asia.Request a sample of this report @ http://orbisresearch.com/contacts/request-sample/2091111This report focuses on the top players in global market, like Agilent TechnologiesBruker CorporationDanaher CorporationMerck KGaANew England BiolabsProZyme, Inc.R Systems, Inc.Shimadzu CorporationTakara Bio, Inc.Thermo Fisher ScientificWaters CorporationMarket segment by Regions/Countries, this report covers United StatesEUJapanChinaIndiaSoutheast AsiaBrowse the complete report @ http://orbisresearch.com/reports/index/global-glycomics-glycobiology-market-size-status-and-forecast-2025Market segment by Type, the product can be split into EnzymesInstrumentsKitsReagentsMarket segment by Application, Glycomics/ Glycobiology can be split into DiagnosticsDrug Discovery & DevelopmentOncologyImmunologyIf you have any special requirements, please let us know and we will offer you the report as you want.Some Points from Table of Content:Chapter One: Industry Overview of Glycomics/ Glycobiology1.1 Glycomics/ Glycobiology Market Overview1.1.1 Glycomics/ Glycobiology Product Scope1.1.2 Market Status and Outlook1.2 Global Glycomics/ Glycobiology Market Size and Analysis by Regions (2013-2018)1.2.1 United States1.2.2 EU1.2.3 Japan1.2.4 China1.2.5 India1.2.6 Southeast Asia1.3 Glycomics/ Glycobiology Market by Type1.3.1 Enzymes1.3.2 Instruments1.3.3 Kits1.3.4 Reagents1.4 Glycomics/ Glycobiology Market by End Users/Application1.4.1 Diagnostics1.4.2 Drug Discovery & Development1.4.3 Oncology1.4.4 ImmunologyChapter Two: Global Glycomics/ Glycobiology Competition Analysis by Players2.1 Glycomics/ Glycobiology Market Size (Value) by Players (2013-2018)2.2 Competitive Status and Trend2.2.1 Market Concentration Rate2.2.2 Product/Service Differences2.2.3 New Entrants2.2.4 The Technology Trends in FuturePlace a purchase order of this report @ http://orbisresearch.com/contact/purchase/2091111About Us:Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements.
We have vast database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our clients.
We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization.
This helps our clients to map their needs and we produce the perfect required market research study for our clients.
DecisionDatabases has published the latest report on Glycomics/Glycobiology Market by manufacturers, regions, type, and application, forecast to 2026.
The report provides in-depth data analysis which will aid with better understanding and decision making.The key market players for the global Glycomics/Glycobiology market are listed below:ThermoFisher ScientificPromegaProZymeDanaherBrukerShimadzu CorporationR SystemsAgilent TechnologiesTakara Bio, Inc.Waters CorporationNew England BiolabsMerck KGaAOthersClick here to get a FREE Sample Copy of the Glycomics/Glycobiology Market Research Report @ https://www.decisiondatabases.com/contact/download-sample-21242The Global Glycomics/Glycobiology Market Report is equipped with market data from 2016 to 2026.
It also evaluates the competitive scenario of the leading players.
This study covers a separate section giving an explicitly clear understanding of the aftereffects of this pandemic.
The detailed study highlights the probable outcomes of this global crisis on the Glycomics/Glycobiology industry.
The impact study on production, supply-demand, and sales provides a holistic approach to the future.Do You Have Any Query Or Report Customization?
You might say the United States is a nation of pill poppers.
Many adults take at least one prescription drug, but it’s not uncommon for older people to be on five or more medications, according to the Centers for Disease Control and Prevention.
Without insurance, the cost may feel so exorbitant you may be tempted to skip or skimp on medication.
Unfortunately, with the way our healthcare system is set up, it can be tough to comparison shop—even your doctor may not know what you’ll end up paying for a prescription.But that doesn’t mean he or she doesn’t want to help you out.
So if there’s even a small chance you may skip the script because of money trouble, it’s better to say so and work on solutions together.)
Even with insurance, drugs can be pricey. Without insurance, the cost may feel so exorbitant you may be tempted to skip or skimp on medication. Don’t. There are ways to rein in the cost of prescription drugs, and skipping medication can be disastrous and ultimately more costly than the drugs themselves.
Original post : Prescription Medication Costs
Psychedelic drug stocks are showing incredible results and recovery in mental health patients without long-lasting side effects.
Many drug candidates are even showing promise in severe depression, PTSD, etc.
Psychedelic drug stocks are showing incredible results and recovery in mental health patients without long-lasting side effects.
Many drug candidates are even showing promise in severe depression, PTSD, etc.
This report studies the global Glycomics/ Glycobiology market, analyzes and researches the Glycomics/ Glycobiology development status and forecast in United States, EU, Japan, China, India and Southeast Asia.Request a sample of this report @ http://orbisresearch.com/contacts/request-sample/2091111This report focuses on the top players in global market, like Agilent TechnologiesBruker CorporationDanaher CorporationMerck KGaANew England BiolabsProZyme, Inc.R Systems, Inc.Shimadzu CorporationTakara Bio, Inc.Thermo Fisher ScientificWaters CorporationMarket segment by Regions/Countries, this report covers United StatesEUJapanChinaIndiaSoutheast AsiaBrowse the complete report @ http://orbisresearch.com/reports/index/global-glycomics-glycobiology-market-size-status-and-forecast-2025Market segment by Type, the product can be split into EnzymesInstrumentsKitsReagentsMarket segment by Application, Glycomics/ Glycobiology can be split into DiagnosticsDrug Discovery & DevelopmentOncologyImmunologyIf you have any special requirements, please let us know and we will offer you the report as you want.Some Points from Table of Content:Chapter One: Industry Overview of Glycomics/ Glycobiology1.1 Glycomics/ Glycobiology Market Overview1.1.1 Glycomics/ Glycobiology Product Scope1.1.2 Market Status and Outlook1.2 Global Glycomics/ Glycobiology Market Size and Analysis by Regions (2013-2018)1.2.1 United States1.2.2 EU1.2.3 Japan1.2.4 China1.2.5 India1.2.6 Southeast Asia1.3 Glycomics/ Glycobiology Market by Type1.3.1 Enzymes1.3.2 Instruments1.3.3 Kits1.3.4 Reagents1.4 Glycomics/ Glycobiology Market by End Users/Application1.4.1 Diagnostics1.4.2 Drug Discovery & Development1.4.3 Oncology1.4.4 ImmunologyChapter Two: Global Glycomics/ Glycobiology Competition Analysis by Players2.1 Glycomics/ Glycobiology Market Size (Value) by Players (2013-2018)2.2 Competitive Status and Trend2.2.1 Market Concentration Rate2.2.2 Product/Service Differences2.2.3 New Entrants2.2.4 The Technology Trends in FuturePlace a purchase order of this report @ http://orbisresearch.com/contact/purchase/2091111About Us:Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements.
We have vast database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our clients.
We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization.
This helps our clients to map their needs and we produce the perfect required market research study for our clients.
DecisionDatabases has published the latest report on Glycomics/Glycobiology Market by manufacturers, regions, type, and application, forecast to 2026.
The report provides in-depth data analysis which will aid with better understanding and decision making.The key market players for the global Glycomics/Glycobiology market are listed below:ThermoFisher ScientificPromegaProZymeDanaherBrukerShimadzu CorporationR SystemsAgilent TechnologiesTakara Bio, Inc.Waters CorporationNew England BiolabsMerck KGaAOthersClick here to get a FREE Sample Copy of the Glycomics/Glycobiology Market Research Report @ https://www.decisiondatabases.com/contact/download-sample-21242The Global Glycomics/Glycobiology Market Report is equipped with market data from 2016 to 2026.
It also evaluates the competitive scenario of the leading players.
This study covers a separate section giving an explicitly clear understanding of the aftereffects of this pandemic.
The detailed study highlights the probable outcomes of this global crisis on the Glycomics/Glycobiology industry.
The impact study on production, supply-demand, and sales provides a holistic approach to the future.Do You Have Any Query Or Report Customization?
You might say the United States is a nation of pill poppers.
Many adults take at least one prescription drug, but it’s not uncommon for older people to be on five or more medications, according to the Centers for Disease Control and Prevention.
Without insurance, the cost may feel so exorbitant you may be tempted to skip or skimp on medication.
Unfortunately, with the way our healthcare system is set up, it can be tough to comparison shop—even your doctor may not know what you’ll end up paying for a prescription.But that doesn’t mean he or she doesn’t want to help you out.
So if there’s even a small chance you may skip the script because of money trouble, it’s better to say so and work on solutions together.)
Even with insurance, drugs can be pricey. Without insurance, the cost may feel so exorbitant you may be tempted to skip or skimp on medication. Don’t. There are ways to rein in the cost of prescription drugs, and skipping medication can be disastrous and ultimately more costly than the drugs themselves.
Original post : Prescription Medication Costs